Gsa Capital Partners LLP Tenaya Therapeutics, Inc. Transaction History
Gsa Capital Partners LLP
- $1.32 Billion
- Q3 2024
A detailed history of Gsa Capital Partners LLP transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 147,932 shares of TNYA stock, worth $221,898. This represents 0.02% of its overall portfolio holdings.
Number of Shares
147,932
Previous 182,062
18.75%
Holding current value
$221,898
Previous $564,000
49.29%
% of portfolio
0.02%
Previous 0.04%
Shares
8 transactions
Others Institutions Holding TNYA
# of Institutions
96Shares Held
56.3MCall Options Held
900Put Options Held
400-
Column Group LLC San Francisco, CA9.4MShares$14.1 Million26.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.98MShares$10.5 Million0.19% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$10.1 Million1.01% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$6.11 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$4.82 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $62M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...